GFAP and Alzheimer disease: Furthermore, studies using astrocyte counting, via Nissl assays [101] or constitutive astrocyte markers in combination with GFAP [102], showed no difference in the number of cells between the brain affected by Alzheimer’s disease and the intact brain.